Sickle cell disease was thought to be cured using gene therapy, but longer term follow up reveals that while the condition improves many are not cured. Now a new approach developed at Johns Hopkins and around the world uses ‘half-matched’ … <a class="more-link" href="https://podcasts.hopkinsmedicine.org/sickle-cell-disease-should-be-treated-with-a-half-matched-donor-approach-elizabeth-tracey-reports/"> Sickle cell disease should be treated with a half-matched donor approach, Elizabeth Tracey reports Read More »</a>

Sickle cell disease was thought to be cured using gene therapy, but longer term follow up reveals that while the condition improves many are not cured. Now a new approach developed at Johns Hopkins and around the world uses ‘half-matched’ … Sickle cell disease should be treated with a half-matched donor approach, Elizabeth Tracey reports Read More »

Sickle cell disease was thought to be cured using gene therapy, but longer term follow up reveals that while the condition improves many are not cured. Now a new approach developed at Johns Hopkins and around the world uses ‘half-matched’ … <a href="https://podcasts.hopkinsmedicine.org/sickle-cell-disease-should-be-treated-with-a-half-matched-donor-approach-elizabeth-tracey-reports/" rel="noopener noreferrer"> Sickle cell disease should be treated with a half-matched donor approach, Elizabeth Tracey reports Read More »</a>

Share Sickle cell disease should be treated with a half-matched donor approach, Elizabeth Tracey reports

Sign up to save your podcasts

Sickle cell disease should be treated with a half-matched donor approach, Elizabeth Tracey reports

Sickle cell disease should be treated with a half-matched donor approach, Elizabeth Tracey reports